1 Nov 2018 - 2 Nov 2018 / Potsdam-Golm, Germany
Hero Image
1 Nov 2018 - 2 Nov 2018
Potsdam-Golm, Germany
10th Potsdam Days on Bioanalysis 2018

Challenges of developing bioanalytics and diagnostics - Cooperation Meets Innovation

© REDPIXEL – fotolia.com
© REDPIXEL – fotolia.com

Introduction

Often, the implementation of goal-oriented and profitable cooperations is quite a challenge, in particular when it comes to innovative product developments in the fields of diagnostics and analytics. Typically, challenges lie within finding the right cooperation partners, identifying transfer points and interpreting results for a quick market launch. Cooperations, though, are not only part of developing new products, but also foster creating knowledge, expanding value chains and connecting sales channels. Well-done cooperations cater to both corporate and societal success. Therefore, this event will lead participants along the value chains of analytics and diagnostics. Bringing together all necessary partners in these fields, this opens up opportunities to establish and operate new cooperations. 

Introduced and presented by an internationally renowned innovation manager, aspects of visionary concepts, operating rules as well as societal and political requirements take a central position. In addition to introducing specific innovations within diagnostics and bioanalysis, the focus will be on describing typical challenges when creating and operating cooperations beyond classical scientific or corporate presentations.The speakers will give deep insights into their cooperation projects. They will reveal what went well, what could be done better and what they wish for.


Potsdam Days on Bioanalysis 2018

Frequently, the “Potsdam Days on Bioanalysis” provide an excellent platform for researchers, clinicians and entrepreneurs to discuss diagnostics’ hot topics, trends and recent developments as well as new areas of application and future markets.

 

From biomarker to detection devices to the final product: What challenges exist in the development of IVD along the value chain?

The path from the discovery of the first biomarker to the final diagnostic device is long and includes many pitfalls that can end a project prematurely. The first part of the Potsdam Days is dedicated to this topic and shows how cooperation beyond the narrow limits of one's own thematic field can lead to new developments.

Quo vadis IVD?

With regard to new regulations and business models - especially in the use and processing of large volumes of data - the question arises as to where the future challenges in diagnostics lie. Will the value creation in ten years still be in the sales of the diagnostic systems, or will a profit only be possible with the processing of the related data? These questions will be discussed on the afternoon of November 1st.

Infection Diseases: New challenges and innovative solutions

The development of vaccinations and antibiotics has steadily reduced attention to the risk of infectious diseases. However, due to vaccination fatigue and increasingly resistant pathogens as well as worldwide passenger and goods traffic, the danger of new epidemics rises again and infectious diseases get back in the focus of attention.

On the second day of the Potsdam Days, the challenges of infection diagnostics are addressed and new developments in the field of detection devices will be presented.

  

Organized by the Cluster Health Capital in cooperation with Fraunhofer IZI-BB, the Potsdam Days on Bioanalysis 2018 will again attract national and international specialists.

Be part of it! Join us for an insight into the field of in vitro diagnostics and point of care testing and make the connections that matter.

Support

...
...


Funded by the State of Berlin and the State of Brandenburg as well as the Investitions- und Landesbank Brandenburg, cofunded by the European Union – European Regional Development Fund.

Registration

Closed since 31 October 2018

Location

IAP Fraunhofer Conference Center

Organised by

Participants

Australia 1
Austria 1
Denmark 1
Germany 107
Japan 1
Switzerland 1
United States 1
Total 113

Participants

Company 61
University 21
R&D Institution 12
Association/Agency 5
Authority/Government 1
Other 13
Total 113